New guidance on the control of Chlamydia trachomatis

Printer-friendly version Printer Friendly Version
Email Story Send This Story

September 2009
Chlamydia trachomatis, the most common bacterial sexually transmitted infection in Europe, continues to increase in many countries according to the European Centre for Disease Prevention and Control (ECDC). It affects mostly young adults under 25, and true occurrence of Chlamydia is most likely much higher than the official figures because the majority of those infected do not have clinical symptoms.

Surveys in European countries have shown an estimated population prevalence of 5–10% in young people; however, a systematic survey of Chlamydia control activities in 29 European countries found wide variation in the organisation of such activities. Almost half of the countries reported no organised activity, and national control programmes were only identified in two countries.

Now, new ECDC guidance, which was unveiled and discussed at the International Society of Sexual Transmitted Disease Research conference held at the end of June at the Queen Elizabeth II Conference Centre in London, will facilitate and support the development of national control strategies for an infection that causes a high burden of disease and other complications (eg ectopic pregnancies and infertility).

The first step to a comprehensive and effective control programme will be the adoption of a control strategy based on wide consultation with key stakeholders. This should take into account the specific national opportunities and limitations, and provide a review of the evidence for the interventions and measures proposed.
www.ecdc.europa.eu


Printer-friendly version Printer Friendly Version
Email Story Send This Story
Supplier Search
Story Search

FEATURE ARTICLE

Supporting pathology partners: long-term training options are now available
Rapidly evolving changes in pathology configurations require ongoing support, training and education. This is where Siemens Academy Training and Education Centre, which opened towards the end of last year, can help hard-pressed laboratory staff. The move towards the commercialisation of pathology, coupled with an increase in diagnostic testing and technologies, has placed more pressure on laboratories to reconfigure services for efficiency and quality.

PRODUCT ARTICLE

Rubella monoclonal antibodies
The rubella virus is the cause of German measles, and infection in children results in a rash but is usually mild and of short duration. However, pregnant women who become infected are susceptible to a more serious condition that can lead to congenital rubella syndrome of the fetus. Thus, serological detection, especially for IgM antibody, is crucial for early intervention.